Evaluation of real-life outcome data of patients with spinal muscular atrophy treated with nusinersen in Switzerland

Autor: Anne Tscherter, Christina T. Rüsch, Dominique Baumann, Cornelia Enzmann, Oswald Hasselmann, David Jacquier, Hans H. Jung, Michelle E. Kruijshaar, Claudia E. Kuehni, Christoph Neuwirth, Georg M. Stettner, Andrea Klein, Nadine Lötscher, Gian P. Ramelli, Paolo Ripellino, Oliver Scheidegger, David-Alexander Wille

Publikováno v: Tscherter, Anne; Rüsch, Christina T; Baumann, Dominique; Enzmann, Cornelia; Hasselmann, Oswald; Jacquier, David; Jung, Hans H; Kruijshaar, Michelle E; Kuehni, Claudia E; Neuwirth, Christoph; Stettner, Georg M; Klein, Andrea (2022). Evaluation of real-life outcome data of patients with spinal muscular atrophy treated with nusinersen in Switzerland. Neuromuscular disorders, 32(5), pp. 399-409. Elsevier 10.1016/j.nmd.2022.02.001
Neuromuscular Disorders, 32(5), 399-409. Elsevier Ltd.

Spinal muscular atrophy (SMA) is an autosomal recessive disorder causing progressive proximal muscular, respiratory, and bulbar weakness. We present outcome data on motor function, ventilation, nutrition, and language development of SMA patients trea

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::471abdfcbdd228784da0f561145baffa
https://doi.org/10.5167/uzh-223821